Inspection Record

Omega Laboratories Ltd. (now Juno Pharma Canada Inc.) — Health Canada Inspection Findings

Health CanadaInspected 2021-12-07 5 findingsComputer system validationOther quality systemStability and storageEquipment and facilityDeviation, CAPA, and investigation

View the regulator's official source The source document is always the basis for judgement.

Findings

1Computer system validation

The calibration, inspection, and/or qualification of the equipment, including computerized systems, was inadequate.

2Other quality system

The receipt, preparation, and/or handling of reagents and culture media was inadequate. The traceability, legibility, documentation, formatting, and/or the accuracy of records was inadequate.

3Stability and storage

The ongoing stability program for a drug was inadequate.

4Equipment and facility

The establishment and/or the maintenance of a data governance plan was inadequate.

5Deviation, CAPA, and investigation

The investigation, handling, and/or reporting of test results that were out-of-specification was inadequate.

About this record

Extracted automatically from the document of the Health Canada inspection on 2021-12-07. The source is available at the link above.

This is a record of that moment. Inspection findings are usually followed by the company's response and corrective action, but this page does not know how that turned out. Do not read it as the current state; check the regulator's official announcements for the latest status.

Translation and classification are automated and may differ in nuance from the source.

Other records for this company

Omega Laboratories Ltd. (now Juno Pharma Canada Inc.) findings history — including this company's other documents Health Canada documents, 2021 Go to Findings search